Drug ID: | NPD2613 |
Drug Name: | |
Molecular Formula: | C17H23NO4 |
Canonical SMILES: | OC[C@H](c1ccccc1)C(=O)O[C@H]1C[C@@H]2C[C@@H]([C@H](C1)N2C)O |
Standard InCHI: | InChI=1S/C17H23NO4/c1-18-12-7-13(9-15(18)16(20)8-12)22-17(21)14(10-19)11-5-3-2-4-6-11/h2-6,12-16,19-20H,7-10H2,1H3/t12-,13+,14-,15+,16+/m1/s1 |
Standard InCHIKey: | WTQYWNWRJNXDEG-LEOABGAYSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNAP001613 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 183088 |
ChEBI | |
CAS Number |
Molecular Weight | 305.16 |
ALogP | -2.0949 |
MLogP | 2.78 |
XLogP | 2.508 |
HDA | 5 |
HBD | 2 |
Rotatable Bonds | 8 |
TPSA | 70 |
RO5 Violation | 0 |